BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21159173)

  • 1. Gene expression of PMP22 is an independent prognostic factor for disease-free and overall survival in breast cancer patients.
    Tong D; Heinze G; Pils D; Wolf A; Singer CF; Concin N; Hofstetter G; Schiebel I; Rudas M; Zeillinger R
    BMC Cancer; 2010 Dec; 10():682. PubMed ID: 21159173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disseminated tumor cells in bone marrow assessed by TWIST1, cytokeratin 19, and mammaglobin A mRNA predict clinical outcome in operable breast cancer patients.
    Tjensvoll K; Oltedal S; Farmen RK; Shammas FV; Heikkilä R; Kvaløy JT; Gilje B; Smaaland R; Nordgård O
    Clin Breast Cancer; 2010 Oct; 10(5):378-84. PubMed ID: 20920982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer.
    Shubbar E; Helou K; Kovács A; Nemes S; Hajizadeh S; Enerbäck C; Einbeigi Z
    BMC Cancer; 2013 Feb; 13():47. PubMed ID: 23374458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome.
    Shubbar E; Kovács A; Hajizadeh S; Parris TZ; Nemes S; Gunnarsdóttir K; Einbeigi Z; Karlsson P; Helou K
    BMC Cancer; 2013 Jan; 13():1. PubMed ID: 23282137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer: Role of IGF-1 and IGFBP-3 expression in prognostication.
    Raval A; Trivedi S
    Indian J Exp Biol; 2016 Oct; 54(10):619-629. PubMed ID: 30084561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast.
    Zhao H
    Breast Cancer; 2021 Jan; 28(1):187-195. PubMed ID: 32812198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients.
    Esteban JM; Felder B; Ahn C; Simpson JF; Battifora H; Shively JE
    Cancer; 1994 Sep; 74(5):1575-83. PubMed ID: 7914825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ESPL1 is a candidate oncogene of luminal B breast cancers.
    Finetti P; Guille A; Adelaide J; Birnbaum D; Chaffanet M; Bertucci F
    Breast Cancer Res Treat; 2014 Aug; 147(1):51-9. PubMed ID: 25086634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes in patients with early-stage breast cancer who underwent a 21-gene expression assay.
    Barcenas CH; Raghavendra A; Sinha AK; Syed MP; Hsu L; Patangan MG; Chavez-MacGregor M; Shen Y; Hortobagyi GH; Valero V; Giordano SH; Ueno NT; Tripathy D
    Cancer; 2017 Jul; 123(13):2422-2431. PubMed ID: 28199747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting early brain metastases based on clinicopathological factors and gene expression analysis in advanced HER2-positive breast cancer patients.
    Duchnowska R; Jassem J; Goswami CP; Dundar M; Gökmen-Polar Y; Li L; Woditschka S; Biernat W; Sosińska-Mielcarek K; Czartoryska-Arłukowicz B; Radecka B; Tomasevic Z; Stępniak P; Wojdan K; Sledge GW; Steeg PS; Badve S
    J Neurooncol; 2015 Mar; 122(1):205-16. PubMed ID: 25559688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
    Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
    Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression Analysis of miR-29b in Malignant and Benign Breast Tumors: A Promising Prognostic Biomarker for Invasive Ductal Carcinoma With a Possible Histotype-Related Expression Status.
    Papachristopoulou G; Papadopoulos EI; Nonni A; Rassidakis GZ; Scorilas A
    Clin Breast Cancer; 2018 Aug; 18(4):305-312.e3. PubMed ID: 29422258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological and prognostic associations of miR-205 and let-7b in breast cancer revealed by in situ hybridization analysis of micro-RNA expression in arrays of archival tumour tissue.
    Quesne JL; Jones J; Warren J; Dawson SJ; Ali HR; Bardwell H; Blows F; Pharoah P; Caldas C
    J Pathol; 2012 Jul; 227(3):306-14. PubMed ID: 22294324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Estrogen Receptor Alpha and Interleukin 6 Polymorphisms with Lymphovascular Invasion, Extranodal Extension, and Lower Disease-Free Survival in Thai Breast Cancer Patients.
    Sa-Nguanraksa D; Suntiparpluacha M; Kulprom A; Kummalue T; Chuangsuwanich T; Avirutnan P; O-Charoenrat P
    Asian Pac J Cancer Prev; 2016; 17(6):2935-40. PubMed ID: 27356714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis.
    Thorat MA; Marchio C; Morimiya A; Savage K; Nakshatri H; Reis-Filho JS; Badve S
    J Clin Pathol; 2008 Mar; 61(3):327-32. PubMed ID: 18037662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Role of PTEN Gene Expression and Length of Survival of Breast Cancer Patients in the North East of Iran.
    Golmohammadi R; Rakhshani MH; Moslem AR; Pejhan A
    Asian Pac J Cancer Prev; 2016; 17(S3):305-9. PubMed ID: 27165243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of ER and PR status in breast cancer using the QuantiGene2.0 assay.
    Chae BJ; Bae JS; Yim HW; Lee A; Song BJ; Jeon HM; Chun MH; Jung SS
    Pathology; 2011 Apr; 43(3):248-53. PubMed ID: 21436635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High TIMM17A expression is associated with adverse pathological and clinical outcomes in human breast cancer.
    Salhab M; Patani N; Jiang W; Mokbel K
    Breast Cancer; 2012 Apr; 19(2):153-60. PubMed ID: 20972741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Keratin 17 is overexpressed and predicts poor survival in estrogen receptor-negative/human epidermal growth factor receptor-2-negative breast cancer.
    Merkin RD; Vanner EA; Romeiser JL; Shroyer ALW; Escobar-Hoyos LF; Li J; Powers RS; Burke S; Shroyer KR
    Hum Pathol; 2017 Apr; 62():23-32. PubMed ID: 27816721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer patients with hypermethylation in the promoter of BRCA1 gene exhibit favorable clinical status.
    Krasteva ME; Bozhanov SS; Antov GG; Gospodinova ZI; Angelov SG
    Neoplasma; 2012; 59(1):85-91. PubMed ID: 22103901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.